Protective Vaccine Against Staphylococcus Aureus Biofilms Comprising Cell Wall-associated Immunogens
Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of using the vaccine formulations in the treatment, prevention and prophylaxis of Staphylococcus aureus infections in a subject.
Patents:WO 2,010,039,563
Inventor(s):
SHIRTLIFF MARK E [US]; O'MAY GRAEME [US]; LEID JEFF [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents